Taku Hashimoto

Dimeric but not Monomeric Soluble CD40 Prolongs Allograft Survival and Generates Regulatory T Cells that Inhibit CTL Function

A. Imai, S. Todo, Nan Hua, 2005, Transplantation.

Rare case of idiopathic sclerosing cholangitis, which was difficult to distinguish from cholangiocarcinoma: A case report

A. Taketomi, T. Einama, K. Nakachi, 2018, Experimental and therapeutic medicine.

L-Carnitine supplementation reduces the general fatigue of cancer patients during chemotherapy

J. Yamamoto, A. Taketomi, T. Einama, 2018, Molecular and clinical oncology.

Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies

S. Todo, M. Murakami, Nan Hua, 2003, Transplantation.

Stromal Cell–Derived Factor-1 and CXCR4 Interaction Is Critical for Development of Transplant Arteriosclerosis

S. Todo, K. Yamashita, M. Inobe, 2004, Circulation.

Gene Therapy-Mediated CD40L and CD28 Co-stimulatory Signaling Blockade plus Transient Anti-xenograft Antibody Suppression Induces Long-Term Acceptance of Cardiac Xenografts

S. Todo, Nan Hua, K. Yamashita, 2004, Transplantation.

27months Recurrence-free Survival Case of Endcrine Cell Carcinoma of the Ampullary of Vater after Adjvant Chemotherapy

Taku Hashimoto, Tomo Nakagawa, Yasuhiro Tani, 2010 .

Long-term survival and prognosis associated with conversion surgery in patients with metastatic gastric cancer

A. Taketomi, T. Einama, S. Homma, 2017, Molecular and clinical oncology.